The UK’s statutory scheme revision for branded medicines
by Giuliana Miglierini The amendment of the statutory schemeregulating the increase in pricing and consequent clawback payments of…
UK will participate to European research programmes
by Giuliana Miglierini The divergent road opened as a consequence of the Brexit, in January 2021, between the…
The Windsor Framework
On 27 February 2023, UK Prime Minister Rishi Sunak and the European Commission President Ursula von der Leyen…
EFPIA’s Annual Report on the Pharmaceutical industry 2022
by Giuliana Miglierini “In the 21 years from 2000 to 2021 – in which time we’ve come through…
Horizon Europe Association – Statement on behalf of the European Health Stakeholder Group
As representatives of the European Union’s health community, we are united in our call for the United Kingdom’s…